BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18288757)

  • 1. Drug-eluting stenting of unprotected left main coronary artery stenosis in patients with orthotopic heart transplantation: Initial clinical experience.
    Lee MS; Chun KJ; Tobis JM
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):306-11. PubMed ID: 18288757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation.
    Lee MS; Yang T; Fearon WF; Ho M; Tarantini G; Xhaxho J; Gerosa G; Weston M; Ehdaie A; Rabbani L; Kirtane AJ
    Am J Cardiol; 2010 Oct; 106(8):1086-9. PubMed ID: 20920643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of percutaneous coronary intervention in transplant coronary artery disease in pediatric heart transplant recipients.
    Lee MS; Sachdeva R; Kim MH; Sachdeva R
    J Invasive Cardiol; 2012 Jun; 24(6):278-81. PubMed ID: 22684382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy.
    Lee MS; Kobashigawa J; Tobis J
    JACC Cardiovasc Interv; 2008 Dec; 1(6):710-5. PubMed ID: 19463388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry.
    Buszman PE; Buszman PP; Kiesz RS; Bochenek A; Trela B; Konkolewska M; Wallace-Bradley D; Wilczyński M; Banasiewicz-Szkróbka I; Peszek-Przybyla E; Krol M; Kondys M; Milewski K; Wiernek S; Debiński M; Zurakowski A; Martin JL; Tendera M
    J Am Coll Cardiol; 2009 Oct; 54(16):1500-11. PubMed ID: 19699048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of left main coronary artery stenosis with drug-eluting stent following heart transplantation.
    Xue YZ; Liu WT; Wang XH; Gao H; Wang LX
    Intern Med; 2012; 51(9):1037-41. PubMed ID: 22576383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unprotected left main coronary artery percutaneous coronary intervention in a pediatric patient with cardiac allograft vasculopathy.
    Tadwalkar RV; Lee MS
    J Invasive Cardiol; 2014 Nov; 26(11):E156-60. PubMed ID: 25364007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting.
    Barlis P; Horrigan M; Elis S; Chan R; Wong M; Farouque O; Proimos G; Ajani AE; Clark DJ
    Cardiovasc Revasc Med; 2007; 8(2):84-9. PubMed ID: 17574165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention and drug-eluting stents in patients with unprotected left main coronary artery narrowings.
    Lee MS; Yang T; Dhoot J; Liao H
    Am J Cardiol; 2010 Apr; 105(8):1070-5. PubMed ID: 20381655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provisional stenting for multivessel PCI.
    Han B; Liu L; Aboud M; Nahir M; Hasin Y
    Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy.
    Tanaka K; Li H; Curran PJ; Takano Y; Arbit B; Currier JW; Yeatman LA; Kobashigawa JA; Tobis JM
    Am J Cardiol; 2006 Apr; 97(8):1192-7. PubMed ID: 16616025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008.
    Brennan JM; Dai D; Patel MR; Rao SV; Armstrong EJ; Messenger JC; Curtis JP; Shunk KA; Anstrom KJ; Eisenstein EL; Weintraub WS; Peterson ED; Douglas PS; Hillegass WB
    J Am Coll Cardiol; 2012 Feb; 59(7):648-54. PubMed ID: 22322080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stent for unprotected left main coronary artery disease: early and mid-term outcomes.
    Tassanawiwat W; Mahavanakul W; Thanakitcharu P; Komolsart P; Chansod S; Sookananchai B; Wongvipaporn C; Kiatchoosakun S; Cheiniwat S; Tresukosol D
    J Med Assoc Thai; 2010 Sep; 93(9):1030-6. PubMed ID: 20873074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease.
    Yang JH; Gwon HC; Cho SJ; Hahn JY; Choi JH; Choi SH; Lee YT; Lee SH; Hong KP; Park JE
    Ann Thorac Surg; 2008 Jan; 85(1):65-70. PubMed ID: 18154782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization and outcomes of unprotected left main coronary artery stenting and coronary artery bypass graft surgery.
    Wu C; Hannan EL; Walford G; Faxon DP
    Ann Thorac Surg; 2008 Oct; 86(4):1153-9. PubMed ID: 18805151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: complete 2-year follow-up of a two-center registry.
    Park KW; Kang SH; Park KH; Choi DH; Lee HY; Kang HJ; Cho YS; Yeon TJ; Chung WY; Koo BK; Chae IH; Choi DJ; Oh BH; Park YB; Kim HS
    Int J Cardiol; 2011 Aug; 151(1):89-95. PubMed ID: 20605240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angioplasty of unprotected left main coronary stenosis: Real world experience of a single-operator group from eastern India.
    Ray S; Mazumder A; Kumar S; Bhattacharjee P; Rozario D; Bandyopadhyay S; Mukherjee SS; Deb PK; Bandyopadhyay A
    Indian Heart J; 2016; 68(1):28-35. PubMed ID: 26896263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.